Agüero, R.; Buchanan, K.L.; Navarrete-Dechent, C.; Marghoob, A.A.; Stein, J.A.; Landy, M.S.; Leachman, S.A.; Linden, K.G.; Garcet, S.; Krueger, J.G.;
et al. The Impact of Melanoma Imaging Biomarker Cues on Detection Sensitivity and Specificity in Melanoma versus Clinically Atypical Nevi. Cancers 2024, 16, 3077.
https://doi.org/10.3390/cancers16173077
AMA Style
Agüero R, Buchanan KL, Navarrete-Dechent C, Marghoob AA, Stein JA, Landy MS, Leachman SA, Linden KG, Garcet S, Krueger JG,
et al. The Impact of Melanoma Imaging Biomarker Cues on Detection Sensitivity and Specificity in Melanoma versus Clinically Atypical Nevi. Cancers. 2024; 16(17):3077.
https://doi.org/10.3390/cancers16173077
Chicago/Turabian Style
Agüero, Rosario, Kendall L. Buchanan, Cristián Navarrete-Dechent, Ashfaq A. Marghoob, Jennifer A. Stein, Michael S. Landy, Sancy A. Leachman, Kenneth G. Linden, Sandra Garcet, James G. Krueger,
and et al. 2024. "The Impact of Melanoma Imaging Biomarker Cues on Detection Sensitivity and Specificity in Melanoma versus Clinically Atypical Nevi" Cancers 16, no. 17: 3077.
https://doi.org/10.3390/cancers16173077
APA Style
Agüero, R., Buchanan, K. L., Navarrete-Dechent, C., Marghoob, A. A., Stein, J. A., Landy, M. S., Leachman, S. A., Linden, K. G., Garcet, S., Krueger, J. G., & Gareau, D. S.
(2024). The Impact of Melanoma Imaging Biomarker Cues on Detection Sensitivity and Specificity in Melanoma versus Clinically Atypical Nevi. Cancers, 16(17), 3077.
https://doi.org/10.3390/cancers16173077